Comparative immunological evaluation of recombinant Salmonella Typhimurium strains expressing model antigens as live oral vaccines

[1]  Eric J. W. Visser,et al.  Abramoff MD, Magalhaes PJ, Ram SJ. 2004. Image Processing with ImageJ. Biophotonics , 2012 .

[2]  K. Yuen,et al.  A method to generate recombinant Salmonella typhi Ty21a strains expressing multiple heterologous genes using an improved recombineering strategy , 2011, Applied Microbiology and Biotechnology.

[3]  W. Kong,et al.  Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. , 2011, Vaccine.

[4]  Wei Sun,et al.  Comparison of a Regulated Delayed Antigen Synthesis System with In Vivo-Inducible Promoters for Antigen Delivery by Live Attenuated Salmonella Vaccines , 2010, Infection and Immunity.

[5]  B. Hargis,et al.  Development and evaluation of candidate recombinant Salmonella-vectored Salmonella vaccines. , 2010, Poultry science.

[6]  K. Liljebjelke,et al.  Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza. , 2010, Vaccine.

[7]  J. Queiroz,et al.  Influence of growth conditions on plasmid DNA production. , 2009, Journal of microbiology and biotechnology.

[8]  A. Williamson,et al.  An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice , 2009, Gut pathogens.

[9]  A. Danchin,et al.  Small noncoding RNA GcvB is a novel regulator of acid resistance in Escherichia coli , 2009, BMC Genomics.

[10]  S. Djordjevic,et al.  Development of Non-Antibiotic-Resistant, Chromosomally Based, Constitutive and Inducible Expression Systems for aroA-Attenuated Salmonella enterica Serovar Typhimurium , 2009, Infection and Immunity.

[11]  Jianfang Ning,et al.  Oral delivery of DNA vaccine encoding VP28 against white spot syndrome virus in crayfish by attenuated Salmonella typhimurium. , 2009, Vaccine.

[12]  Lin Sun,et al.  Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus. , 2009, Vaccine.

[13]  A. Abdul-Wahid,et al.  Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle. , 2007, Vaccine.

[14]  Jianguo Wu,et al.  Type IVB Pilus Operon Promoter Controlling Expression of the Severe Acute Respiratory Syndrome-Associated Coronavirus Nucleocapsid Gene in Salmonella enterica Serovar Typhi Elicits Full Immune Response by Intranasal Vaccination , 2007, Clinical and Vaccine Immunology.

[15]  R. Isoda,et al.  Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector. , 2007, Vaccine.

[16]  Rino Rappuoli,et al.  Vaccine manufacturing: challenges and solutions , 2006, Nature Biotechnology.

[17]  N. Costantino,et al.  A set of recombineering plasmids for gram-negative bacteria. , 2006, Gene.

[18]  Steve Oh,et al.  Global transcriptional analysis of metabolic burden due to plasmid maintenance in Escherichia coli DH5α during batch fermentation , 2006 .

[19]  W. Fang,et al.  Attenuated Salmonella typhimurium as a Carrier for Prokaryotic and Eukaryotic Expression Vectors , 2006 .

[20]  D. Maskell,et al.  Salmonella Infections: Clinical, Immunological and Molecular Aspects , 2006 .

[21]  David J Brayden,et al.  Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting. , 2005, Drug discovery today.

[22]  S. McSorley,et al.  Tracking the dynamics of T‐cell activation in response to Salmonella infection , 2005, Immunology.

[23]  T. Chakraborty,et al.  Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids , 2005, Gene Therapy.

[24]  Meng Yang,et al.  Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Weiss,et al.  Bacteria-mediated DNA transfer in gene therapy and vaccination , 2004, Expert opinion on biological therapy.

[26]  S. Dunstan,et al.  In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium. , 2003, FEMS immunology and medical microbiology.

[27]  K. Brown,et al.  Construction and evaluation of a eukaryotic expression plasmid for stable delivery using attenuated Salmonella. , 2003, Microbial pathogenesis.

[28]  S. Weiss.  Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp. , 2003, International journal of medical microbiology : IJMM.

[29]  Tomoko Yamamoto.  [Genus Salmonella]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[30]  K. Yuen,et al.  Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. , 2001, Vaccine.

[31]  C. Guzmán,et al.  Use of live bacterial vaccine vectors for antigen delivery: potential and limitations. , 2001, Vaccine.

[32]  S. Weiss,et al.  Bacteria-Mediated Transfer of Eukaryotic Expression Plasmids into Mammalian Host Cells , 2001, Biological chemistry.

[33]  D. Seigneurin.  [Cytometry]. , 2020, Annales de Pathologie.

[34]  V. Cicinnati,et al.  Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope , 2000, Gene Therapy.

[35]  Chul-Joong Kim,et al.  Surface-displayed viral antigens on Salmonella carrier vaccine , 2000, Nature Biotechnology.

[36]  M. Hensel,et al.  Salmonella Pathogenicity Island 2 , 2000, Molecular microbiology.

[37]  T. Chakraborty,et al.  Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. , 2000, FEMS immunology and medical microbiology.

[38]  G. Lewis,et al.  Recent advances with recombinant bacterial vaccine vectors. , 2000, Molecular medicine today.

[39]  J. D. Díaz Ricci,et al.  Plasmid Effects on Escherichia coli Metabolism , 2000, Critical reviews in biotechnology.

[40]  L. McDaniel,et al.  A Live Recombinant Avirulent Oral Salmonella Vaccine Expressing Pneumococcal Surface Protein A Induces Protective Responses against Streptococcus pneumoniae , 1998, Infection and Immunity.

[41]  K. Timmis,et al.  Oral Somatic Transgene Vaccination Using Attenuated S. typhimurium , 1997, Cell.

[42]  J. Mcghee,et al.  Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses. , 1996, Journal of biotechnology.

[43]  S. Kaufmann,et al.  Salmonella enterica infection. , 1996, Research in immunology.

[44]  M. Mayer,et al.  A new set of useful cloning and expression vectors derived from pBlueScript. , 1995, Gene.

[45]  T. Hadfield.  CLINICAL VIROLOGY MANUAL , 1995 .

[46]  D. O’hagan.  Novel Delivery Systems for Oral Vaccines , 1994 .

[47]  R. Titball,et al.  Effect of different plasmids on colonization of mouse tissues by the aromatic amino acid dependent Salmonella typhimurium SL 3261. , 1994, Microbial pathogenesis.

[48]  R. Titball,et al.  Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. , 1994, Vaccine.

[49]  J. Bion,et al.  Antibiotic-induced release of endotoxin from bacteria in vitro. , 1994, Journal of medical microbiology.

[50]  S. Turner,et al.  Salmonella typhimurium delta aroA delta aroD mutants expressing a foreign recombinant protein induce specific major histocompatibility complex class I-restricted cytotoxic T lymphocytes in mice , 1993, Infection and immunity.

[51]  R. Curtiss,et al.  Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins , 1993, Infection and immunity.

[52]  J. Clements,et al.  Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. , 1993, Vaccine.

[53]  Fulvio Mavilio,et al.  Gene therapy , 1993, Nature.

[54]  W. Goebel,et al.  Identification of p60 antibodies in human sera and presentation of this listerial antigen on the surface of attenuated salmonellae by the HlyB-HlyD secretion system , 1992, Infection and immunity.

[55]  N. Fairweather,et al.  Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains. , 1990, Gene.

[56]  M. Sarvas,et al.  Antibody production to a meningococcal outer membrane protein cloned into liv Salmonella typhimurium aroA vaccine strain. , 1989, Microbial pathogenesis.

[57]  S. Attridge,et al.  A chromosomal integration system for stabilization of heterologous genes in Salmonella based vaccine strains. , 1988, Microbial pathogenesis.

[58]  T. Malinin,et al.  The effect of some beta-lactam antibiotics on Escherichia coli studied by flow cytometry. , 1982, Cytometry.

[59]  K. Bush,et al.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria , 1982, Antimicrobial Agents and Chemotherapy.

[60]  B. Stocker,et al.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines , 1981, Nature.